Lapatinib for inflammatory breast cancer

Lancet Oncol. 2009 Jun;10(6):538-9. doi: 10.1016/S1470-2045(09)70120-2.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / immunology*
  • Female
  • Genes, erbB-2 / genetics
  • Humans
  • Inflammation
  • Lapatinib
  • Quinazolines / therapeutic use*

Substances

  • Antineoplastic Agents
  • Quinazolines
  • Lapatinib